JPH09188806A - 被吸収性ポリオキサエステルのブレンド - Google Patents

被吸収性ポリオキサエステルのブレンド

Info

Publication number: JPH09188806A
Authority: JP; Japan
Prior art keywords: integer; range; formula; group; carbon atoms
Prior art date: 1995-11-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP8310042A

Other languages

English (en)

Japanese (ja)

Inventor

Rao S Bezwada

ラオ・エス・ベズワダ

Dennis D Jamiolkowski

デニス・デイ・ジヤミオルコウスキ

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ethicon Inc

Original Assignee

Ethicon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-06

Filing date

1996-11-06

Publication date

1997-07-22

1996-03-05 Priority claimed from US08/611,119 external-priority patent/US5607687A/en

1996-11-06 Application filed by Ethicon Inc filed Critical Ethicon Inc

1997-07-22 Publication of JPH09188806A publication Critical patent/JPH09188806A/ja

Status Pending legal-status Critical Current

Links

150000002148 esters Chemical class 0.000 title abstract description 6
239000000203 mixture Substances 0.000 title description 21
229920000642 polymer Polymers 0.000 claims abstract description 60
229920002959 polymer blend Polymers 0.000 claims abstract description 34
229920002635 polyurethane Polymers 0.000 claims abstract description 31
239000004814 polyurethane Substances 0.000 claims abstract description 31
150000002596 lactones Chemical class 0.000 claims abstract description 24
125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 23
125000000217 alkyl group Chemical group 0.000 claims abstract description 20
239000004952 Polyamide Substances 0.000 claims abstract description 11
229920002647 polyamide Polymers 0.000 claims abstract description 11
229920002401 polyacrylamide Polymers 0.000 claims abstract description 4
125000001931 aliphatic group Chemical group 0.000 claims description 50
125000004432 carbon atom Chemical group C* 0.000 claims description 40
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 29
239000001257 hydrogen Substances 0.000 claims description 29
229910052739 hydrogen Inorganic materials 0.000 claims description 29
229920001577 copolymer Polymers 0.000 claims description 28
-1 polyethylene copolymer Polymers 0.000 claims description 22
229920001451 polypropylene glycol Polymers 0.000 claims description 21
125000002947 alkylene group Chemical group 0.000 claims description 20
239000003814 drug Substances 0.000 claims description 20
229920000728 polyester Polymers 0.000 claims description 18
229940079593 drug Drugs 0.000 claims description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
229920001519 homopolymer Polymers 0.000 claims description 12
239000011159 matrix material Substances 0.000 claims description 12
239000002202 Polyethylene glycol Substances 0.000 claims description 11
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
229920001223 polyethylene glycol Polymers 0.000 claims description 11
229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 10
229920001311 Poly(hydroxyethyl acrylate) Polymers 0.000 claims description 10
239000004698 Polyethylene Substances 0.000 claims description 10
239000004721 Polyphenylene oxide Substances 0.000 claims description 10
239000004372 Polyvinyl alcohol Substances 0.000 claims description 10
238000012377 drug delivery Methods 0.000 claims description 10
125000005702 oxyalkylene group Chemical group 0.000 claims description 10
229920000570 polyether Polymers 0.000 claims description 10
229920000573 polyethylene Polymers 0.000 claims description 10
229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 10
229920002451 polyvinyl alcohol Polymers 0.000 claims description 10
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 10
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 10
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 10
150000001875 compounds Chemical class 0.000 claims description 3
AXUYQDCVKHKQOW-UHFFFAOYSA-N 2-fluoropropan-2-ol Chemical compound CC(C)(O)F AXUYQDCVKHKQOW-UHFFFAOYSA-N 0.000 claims description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract description 29
150000002009 diols Chemical class 0.000 abstract description 14
239000002253 acid Substances 0.000 abstract description 13
239000003054 catalyst Substances 0.000 abstract description 6
238000002156 mixing Methods 0.000 abstract description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 description 22
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 20
239000000047 product Substances 0.000 description 15
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
239000000178 monomer Substances 0.000 description 12
239000000243 solution Substances 0.000 description 11
229910052757 nitrogen Inorganic materials 0.000 description 10
BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 9
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
239000011541 reaction mixture Substances 0.000 description 9
PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 8
239000007822 coupling agent Substances 0.000 description 7
239000000463 material Substances 0.000 description 7
238000000034 method Methods 0.000 description 7
238000006116 polymerization reaction Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
229920003232 aliphatic polyester Polymers 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
238000006068 polycondensation reaction Methods 0.000 description 6
210000003491 skin Anatomy 0.000 description 6
229940124597 therapeutic agent Drugs 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
230000007062 hydrolysis Effects 0.000 description 5
238000006460 hydrolysis reaction Methods 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
238000003756 stirring Methods 0.000 description 5
YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 5
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 4
CQWXKASOCUAEOW-UHFFFAOYSA-N 2-[2-(carboxymethoxy)ethoxy]acetic acid Chemical compound OC(=O)COCCOCC(O)=O CQWXKASOCUAEOW-UHFFFAOYSA-N 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
125000003118 aryl group Chemical group 0.000 description 4
238000007872 degassing Methods 0.000 description 4
239000007943 implant Substances 0.000 description 4
DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
229920000139 polyethylene terephthalate Polymers 0.000 description 4
239000005020 polyethylene terephthalate Substances 0.000 description 4
239000000376 reactant Substances 0.000 description 4
238000010992 reflux Methods 0.000 description 4
239000007787 solid Substances 0.000 description 4
KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 4
VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
101100025412 Arabidopsis thaliana XI-A gene Proteins 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
238000005481 NMR spectroscopy Methods 0.000 description 3
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
229920000954 Polyglycolide Polymers 0.000 description 3
239000012298 atmosphere Substances 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000000576 coating method Methods 0.000 description 3
239000000835 fiber Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
229910017604 nitric acid Inorganic materials 0.000 description 3
229920001610 polycaprolactone Polymers 0.000 description 3
238000010926 purge Methods 0.000 description 3
230000002792 vascular Effects 0.000 description 3
JJTUDXZGHPGLLC-QWWZWVQMSA-N (3r,6r)-3,6-dimethyl-1,4-dioxane-2,5-dione Chemical compound C[C@H]1OC(=O)[C@@H](C)OC1=O JJTUDXZGHPGLLC-QWWZWVQMSA-N 0.000 description 2
JJTUDXZGHPGLLC-ZXZARUISSA-N (3r,6s)-3,6-dimethyl-1,4-dioxane-2,5-dione Chemical compound C[C@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-ZXZARUISSA-N 0.000 description 2
AOLNDUQWRUPYGE-UHFFFAOYSA-N 1,4-dioxepan-5-one Chemical compound O=C1CCOCCO1 AOLNDUQWRUPYGE-UHFFFAOYSA-N 0.000 description 2
125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
206010019909 Hernia Diseases 0.000 description 2
KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
239000000654 additive Substances 0.000 description 2
229940035676 analgesics Drugs 0.000 description 2
239000000730 antalgic agent Substances 0.000 description 2
QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
239000000316 bone substitute Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
JGFBRKRYDCGYKD-UHFFFAOYSA-N dibutyl(oxo)tin Chemical compound CCCC[Sn](=O)CCCC JGFBRKRYDCGYKD-UHFFFAOYSA-N 0.000 description 2
150000001991 dicarboxylic acids Chemical class 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
230000032050 esterification Effects 0.000 description 2
238000005886 esterification reaction Methods 0.000 description 2
239000004744 fabric Substances 0.000 description 2
210000003195 fascia Anatomy 0.000 description 2
239000007789 gas Substances 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
150000004702 methyl esters Chemical class 0.000 description 2
238000000465 moulding Methods 0.000 description 2
125000002524 organometallic group Chemical group 0.000 description 2
125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
229920000151 polyglycol Polymers 0.000 description 2
239000010695 polyglycol Substances 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
235000013772 propylene glycol Nutrition 0.000 description 2
230000005855 radiation Effects 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
239000002407 tissue scaffold Substances 0.000 description 2
ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
CEGRHPCDLKAHJD-UHFFFAOYSA-N 1,1,1-propanetricarboxylic acid Chemical compound CCC(C(O)=O)(C(O)=O)C(O)=O CEGRHPCDLKAHJD-UHFFFAOYSA-N 0.000 description 1
YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
SJDLIJNQXLJBBE-UHFFFAOYSA-N 1,4-dioxepan-2-one Chemical compound O=C1COCCCO1 SJDLIJNQXLJBBE-UHFFFAOYSA-N 0.000 description 1
HJZZQNLKBWJYPD-UHFFFAOYSA-N 2-[2-[2-(carboxymethoxy)ethoxy]ethoxy]acetic acid Chemical compound OC(=O)COCCOCCOCC(O)=O HJZZQNLKBWJYPD-UHFFFAOYSA-N 0.000 description 1
APLNAFMUEHKRLM-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)N=CN2 APLNAFMUEHKRLM-UHFFFAOYSA-N 0.000 description 1
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
229940127291 Calcium channel antagonist Drugs 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
206010053177 Epidermolysis Diseases 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
239000000150 Sympathomimetic Substances 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical group [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000003978 alpha-halocarboxylic acids Chemical class 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
239000002269 analeptic agent Substances 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
230000003288 anthiarrhythmic effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000001078 anti-cholinergic effect Effects 0.000 description 1
230000001142 anti-diarrhea Effects 0.000 description 1
230000002686 anti-diuretic effect Effects 0.000 description 1
230000003474 anti-emetic effect Effects 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
230000001139 anti-pruritic effect Effects 0.000 description 1
230000001754 anti-pyretic effect Effects 0.000 description 1
230000002921 anti-spasmodic effect Effects 0.000 description 1
239000003416 antiarrhythmic agent Substances 0.000 description 1
229940124346 antiarthritic agent Drugs 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940125681 anticonvulsant agent Drugs 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940005513 antidepressants Drugs 0.000 description 1
229940125714 antidiarrheal agent Drugs 0.000 description 1
239000003793 antidiarrheal agent Substances 0.000 description 1
229940124538 antidiuretic agent Drugs 0.000 description 1
239000002111 antiemetic agent Substances 0.000 description 1
229940125683 antiemetic agent Drugs 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
229940030600 antihypertensive agent Drugs 0.000 description 1
239000002220 antihypertensive agent Substances 0.000 description 1
229960005475 antiinfective agent Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229940005486 antimigraine preparations Drugs 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000003096 antiparasitic agent Substances 0.000 description 1
229940125687 antiparasitic agent Drugs 0.000 description 1
239000003908 antipruritic agent Substances 0.000 description 1
239000000164 antipsychotic agent Substances 0.000 description 1
229940005529 antipsychotics Drugs 0.000 description 1
239000002221 antipyretic Substances 0.000 description 1
229940125716 antipyretic agent Drugs 0.000 description 1
239000003435 antirheumatic agent Substances 0.000 description 1
229940124575 antispasmodic agent Drugs 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000002876 beta blocker Substances 0.000 description 1
229940097320 beta blocking agent Drugs 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
239000000480 calcium channel blocker Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
230000002612 cardiopulmonary effect Effects 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
229940106681 chloroacetic acid Drugs 0.000 description 1
PMMYEEVYMWASQN-IMJSIDKUSA-N cis-4-Hydroxy-L-proline Chemical compound O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
229940037530 cough and cold preparations Drugs 0.000 description 1
239000012043 crude product Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
STZIXLPVKZUAMV-UHFFFAOYSA-N cyclopentane-1,1,2,2-tetracarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCC1(C(O)=O)C(O)=O STZIXLPVKZUAMV-UHFFFAOYSA-N 0.000 description 1
NUUPJBRGQCEZSI-UHFFFAOYSA-N cyclopentane-1,3-diol Chemical compound OC1CCC(O)C1 NUUPJBRGQCEZSI-UHFFFAOYSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
239000000850 decongestant Substances 0.000 description 1
229940124581 decongestants Drugs 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
229940030606 diuretics Drugs 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
229920006244 ethylene-ethyl acrylate Polymers 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000001879 gelation Methods 0.000 description 1
230000009477 glass transition Effects 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
229920000578 graft copolymer Polymers 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
239000003326 hypnotic agent Substances 0.000 description 1
230000000147 hypnotic effect Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000007774 longterm Effects 0.000 description 1
229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
229940127554 medical product Drugs 0.000 description 1
239000000155 melt Substances 0.000 description 1
VGYYKZVYXBJBOU-UHFFFAOYSA-N methyl 2-[2-(2-methoxy-2-oxoethoxy)ethoxy]acetate Chemical compound COC(=O)COCCOCC(=O)OC VGYYKZVYXBJBOU-UHFFFAOYSA-N 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
229940035363 muscle relaxants Drugs 0.000 description 1
239000003158 myorelaxant agent Substances 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
230000001734 parasympathetic effect Effects 0.000 description 1
WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
229960002508 pindolol Drugs 0.000 description 1
PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
239000004632 polycaprolactone Substances 0.000 description 1
229920001225 polyester resin Polymers 0.000 description 1
239000004645 polyester resin Substances 0.000 description 1
230000000379 polymerizing effect Effects 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920000166 polytrimethylene carbonate Polymers 0.000 description 1
238000012545 processing Methods 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
239000003368 psychostimulant agent Substances 0.000 description 1
229920005604 random copolymer Polymers 0.000 description 1
230000008439 repair process Effects 0.000 description 1
229940125723 sedative agent Drugs 0.000 description 1
239000000932 sedative agent Substances 0.000 description 1
239000000779 smoke Substances 0.000 description 1
235000014214 soft drink Nutrition 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000001150 spermicidal effect Effects 0.000 description 1
230000003637 steroidlike Effects 0.000 description 1
239000000829 suppository Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
230000001975 sympathomimetic effect Effects 0.000 description 1
229940064707 sympathomimetics Drugs 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
239000003204 tranquilizing agent Substances 0.000 description 1
230000002936 tranquilizing effect Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
229940124549 vasodilator Drugs 0.000 description 1
239000003071 vasodilator agent Substances 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
238000013022 venting Methods 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)
Polyesters Or Polycarbonates (AREA)
Compositions Of Macromolecular Compounds (AREA)
Medicinal Preparation (AREA)

JP8310042A 1995-11-06 1996-11-06 被吸収性ポリオキサエステルのブレンド Pending JPH09188806A (ja)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US55461495A	1995-11-06	1995-11-06
US554614		1995-11-06
US08/611,119 US5607687A (en)	1995-03-06	1996-03-05	Polymer blends containing absorbable polyoxaesters
US611119		2000-07-06

Publications (1)

Publication Number	Publication Date
JPH09188806A true JPH09188806A (ja)	1997-07-22

Family

ID=27070622

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP8310042A Pending JPH09188806A (ja)	1995-11-06	1996-11-06	被吸収性ポリオキサエステルのブレンド

Country Status (4)

Country	Link
JP (1)	JPH09188806A (fr)
AU (1)	AU707772B2 (fr)
BR (1)	BR9605439A (fr)
CA (1)	CA2189521C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2021008626A (ja) *	2014-12-19	2021-01-28	ポリ−メッドインコーポレイテッド	熱安定性が改善された吸収性コポリマー

1996
- 1996-10-31 AU AU70535/96A patent/AU707772B2/en not_active Ceased
- 1996-11-04 CA CA 2189521 patent/CA2189521C/fr not_active Expired - Fee Related
- 1996-11-06 JP JP8310042A patent/JPH09188806A/ja active Pending
- 1996-11-06 BR BR9605439A patent/BR9605439A/pt not_active Application Discontinuation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2021008626A (ja) *	2014-12-19	2021-01-28	ポリ−メッドインコーポレイテッド	熱安定性が改善された吸収性コポリマー
JP2025010531A (ja) *	2014-12-19	2025-01-21	ポリ－メッドインコーポレイテッド	熱安定性が改善された吸収性コポリマー
US12398236B2 (en)	2014-12-19	2025-08-26	Poly-Med, Inc.	Absorbable copolymers with improved thermal stability

Also Published As

Publication number	Publication date
AU7053596A (en)	1997-05-15
BR9605439A (pt)	1998-08-04
CA2189521A1 (fr)	1997-05-07
AU707772B2 (en)	1999-07-22
CA2189521C (fr)	2005-10-18
MX9605422A (es)	1997-10-31

Legal Events

Date

Code

Title

Description

2004-06-04

A977

Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040604

2004-06-15

A131

Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040615

2004-11-16

A02

Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20041116

Publication	Publication Date	Title
AU720550B2 (en)	2000-06-01	Blends of absorbable polyoxaesters containing amines and/or amido groups
US5607687A (en)	1997-03-04	Polymer blends containing absorbable polyoxaesters
AU719104B2 (en)	2000-05-04	Absorbable polyoxaesters
EP0794211B1 (fr)	2005-12-21	Compositions contenant des polyoxaamides absorbables
EP0731123B1 (fr)	2003-08-13	Polyoxaesters absorbables
US5595751A (en)	1997-01-21	Absorbable polyoxaesters containing amines and/or amido groups
US5700583A (en)	1997-12-23	Hydrogels of absorbable polyoxaesters containing amines or amido groups
US6074660A (en)	2000-06-13	Absorbable polyoxaesters containing amines and/ or amido groups
US20010026793A1 (en)	2001-10-04	Hydrogels containing absorbable polyoxaamides
KR20020032555A (ko)	2002-05-03	흡수성 폴리옥사에스테르를 사용하여 접착을 방지하는 방법
JPH10158375A (ja)	1998-06-16	吸収性ポリオキサエステルのヒドロゲル
EP0771849B1 (fr)	2004-01-28	Mélanges de polymères contenant des polyoxaesters et polymères de lactons
AU707772B2 (en)	1999-07-22	Polymer blends containing polyoxaesters
AU745743B2 (en)	2002-03-28	Blends containing absorbable polyoxaamides
MXPA97001689A (en)	1998-04-01	Absorbib polioxaesters
MXPA96005420A (en)	1998-07-03	Mixtures of absorbable polioxaesteres containing amines and / or am groups
MXPA96005407A (en)	1998-07-03	Movie extruded from a mix eco decopolimeros